Materials for medicine reassessment get stricter

Published: 2017-11-23 16:30:00
Updated: 2017-11-23 15:58:44

In the future, when applying for reassessment for a novel drug, a pharmaceutical company must turn in reference data, such as sales and approval records.

On 21 November, the Ministry of Food and Drug Safety(MFDS) officially announced a partial revision to the ‘Reassessment Standards for Novel Dr...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.